SIMULATIONS PLUS INC (SLP) Stock Price, Forecast & Analysis
USA - NASDAQ:SLP - US8292141053 - Common Stock
SLP Key Statistics, Chart & Performance
The current stock price of SLP is 17.24 USD. In the past month the price increased by 11.09%. In the past year, price decreased by -39.76%.
SLP Latest News, Press Relases and Analysis
SLP Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 39.5 | 48.23B | ||
| DOCS | DOXIMITY INC-CLASS A | 31.2 | 9.58B | ||
| WAY | WAYSTAR HOLDING CORP | 27.28 | 6.98B | ||
| HTFL | HEARTFLOW INC | N/A | 2.61B | ||
| PHR | PHREESIA INC | N/A | 1.37B | ||
| CERT | CERTARA INC | 16.8 | 1.35B | ||
| SDGR | SCHRODINGER INC | N/A | 1.29B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.28B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.08B | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | 625.25 | 1.06B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 8.7 | 1.06B | ||
| CTEV | CLARITEV CORP | N/A | 828.44M |
Related stock screener links
About SLP
Company Profile
Simulations Plus, Inc. engages in the provision of software and consulting services supporting drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. The company is headquartered in Research Triangle Park, North Carolina and currently employs 243 full-time employees. The company operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The firm operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. The company delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
Company Info
SIMULATIONS PLUS INC
800 Park Offices Drive, Suite 401
RESEARCH TRIANGLE PARK NORTH CAROLINA 93534 US
CEO: Shawn O'Connor
Employees: 243
Phone: 16617237723
SIMULATIONS PLUS INC / SLP FAQ
What does SIMULATIONS PLUS INC do?
Simulations Plus, Inc. engages in the provision of software and consulting services supporting drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. The company is headquartered in Research Triangle Park, North Carolina and currently employs 243 full-time employees. The company operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The firm operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. The company delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
What is the current price of SLP stock?
The current stock price of SLP is 17.24 USD. The price decreased by -0.52% in the last trading session.
Does SIMULATIONS PLUS INC pay dividends?
SIMULATIONS PLUS INC (SLP) has a dividend yield of 0.61%. The yearly dividend amount is currently 0.24.
What is the ChartMill rating of SIMULATIONS PLUS INC stock?
SLP has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
What do analysts say about SIMULATIONS PLUS INC (SLP) stock?
11 analysts have analysed SLP and the average price target is 23.46 USD. This implies a price increase of 36.08% is expected in the next year compared to the current price of 17.24.
Can you provide the growth outlook for SIMULATIONS PLUS INC?
The Revenue of SIMULATIONS PLUS INC (SLP) is expected to grow by 10.93% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Can you provide the upcoming earnings date for SIMULATIONS PLUS INC?
SIMULATIONS PLUS INC (SLP) will report earnings on 2025-12-01, after the market close.
SLP Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to SLP. When comparing the yearly performance of all stocks, SLP is a bad performer in the overall market: 78.1% of all stocks are doing better.
SLP Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to SLP. SLP has an excellent financial health rating, but there are some minor concerns on its profitability.
SLP Financial Highlights
Over the last trailing twelve months SLP reported a non-GAAP Earnings per Share(EPS) of 0.65. The EPS increased by 38.3% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -47.03% | ||
| ROE | -51.05% | ||
| Debt/Equity | 0 |
SLP Forecast & Estimates
11 analysts have analysed SLP and the average price target is 23.46 USD. This implies a price increase of 36.08% is expected in the next year compared to the current price of 17.24.
For the next year, analysts expect an EPS growth of -764.23% and a revenue growth 10.93% for SLP